Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC — Stella

Home/Colo-rectal Cancer/Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

View on ClinicalTrials.gov

Recruiting

Back to Colo-rectal Cancer trials

Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

China

SanMing First Hospital, Sanming

Ruijin Hospital, Shanghai

Key details

Phase

Safety & dosing

Sponsor

Ruijin Hospital

Enrollment target

~50 participants

Started

August 2025

Primary completion

August 2027

Age range

60 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.